Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs by Lin Xu, Xu Che

Get full text

Efficacy and safety of anlotinib monotherapy for advanced hepatocellular carcinoma and clinical role of α-fetoprotein by Jianping Chang, Bowen Xu, Zhiyu Li, Zhicheng Wei, Xu Che, Jianqiang Cai, Yanjiang Yin, Xinyu Bi

Get full text

The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis by Wei Zhang, Zirong Liu, Hongjin Liu, Zhangkan Huang, Xiaozhun Huang, Lin Xu, Xu Che, Zhengyin Zhan

Get full text

Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study by Jun-shuai Xue, Nuersimanguli Maimaitiming, Bo-lun Zhang, Bo-wen Xu, Xin Yin, Zhen Huang, Xu Che, Hong Zhao, Jian-qiang Cai

Get full text

Preoperative circulating tumor cells indicate microvascular invasion and dynamical detection indicate the early recurrence of hepatocellular carcinoma by Xiaozhun Huang, Haoxiang Wen, Yan Huang, Wenyan Kang, Zhenyu Lin, Lin Xu, Yihong Ran, Zhangkan Huang, Dong Chen, Heng Zou, Xinyu Bi, Xu Che

Get full text

Engineered EVs from LncEEF1G - overexpressing MSCs promote fibrotic liver regeneration by upregulating HGF release from hepatic stellate cells by Jiebin Zhang, Xiaotong Qiu, Yunguo Lei, Haitian Chen, Dongwei Wu, Tingting Wang, Xin Sui, Jiaqi Xiao, Chenhao Jiang, Huayao Zhang, Yasong Liu, Xiaoquan Liu, Yingcai Zhang, Xu Che, Ye Lin, Jia Yao, Zihao Pan, Rong Li, Jun Zheng

Get full text